We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting

This study has been terminated.
(Therapy for carotid disease has recently changed. Carotid stenting is now restricted to high risk patients that are not eligible for the study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01414387
First Posted: August 11, 2011
Last Update Posted: August 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
American Heart Association
Information provided by (Responsible Party):
Carlos H. Timaran, Dallas VA Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 12, 2016
  Primary Completion Date: February 12, 2016 (Final data collection date for primary outcome measure)